These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 19382090

  • 1. [Pathogenesis and treatment of vascular calcification in CKD].
    Brancaccio D, Gallieni M, Pasho S, Fallabrino G, Olivi L, Volpi E, Ciceri P, Missaglia E, Ronga C, Brambilla C, Butti A, Rocca-Rey L, Chiarelli G, Cozzolino M.
    G Ital Nefrol; 2009; 26 Suppl 45():S20-7. PubMed ID: 19382090
    [Abstract] [Full Text] [Related]

  • 2. Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification.
    Brancaccio D, Bellasi A, Cozzolino M, Galassi A, Gallieni M.
    Curr Vasc Pharmacol; 2009 Jul; 7(3):374-80. PubMed ID: 19601862
    [Abstract] [Full Text] [Related]

  • 3. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [Abstract] [Full Text] [Related]

  • 4. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R.
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [Abstract] [Full Text] [Related]

  • 5. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease.
    Nikolov IG, Mozar A, Drüeke TB, Massy ZA.
    Blood Purif; 2009 Apr; 27(4):350-9. PubMed ID: 19295198
    [Abstract] [Full Text] [Related]

  • 6. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
    Martin KJ, González EA.
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
    [Abstract] [Full Text] [Related]

  • 7. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
    Akiba T.
    Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
    [Abstract] [Full Text] [Related]

  • 8. Vascular calcification in chronic kidney disease.
    Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ.
    Clin Sci (Lond); 2010 Apr 28; 119(3):111-21. PubMed ID: 20443781
    [Abstract] [Full Text] [Related]

  • 9. Ten-year experience with sevelamer and calcium salts as phosphate binders.
    Raggi P, Vukicevic S, Moysés RM, Wesseling K, Spiegel DM.
    Clin J Am Soc Nephrol; 2010 Jan 28; 5 Suppl 1():S31-40. PubMed ID: 20089501
    [Abstract] [Full Text] [Related]

  • 10. Vascular calcification in uremic conditions: new insights into pathogenesis.
    Cozzolino M, Gallieni M, Brancaccio D.
    Semin Nephrol; 2006 Jan 28; 26(1):33-7. PubMed ID: 16412823
    [Abstract] [Full Text] [Related]

  • 11. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A, Sprague SM.
    Adv Chronic Kidney Dis; 2007 Jan 28; 14(1):27-36. PubMed ID: 17200041
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease.
    McCullough PA, Agrawal V, Danielewicz E, Abela GS.
    Clin J Am Soc Nephrol; 2008 Nov 28; 3(6):1585-98. PubMed ID: 18667741
    [Abstract] [Full Text] [Related]

  • 14. Vascular calcification in patients with chronic kidney disease.
    Nitta K.
    Ther Apher Dial; 2011 Dec 28; 15(6):513-21. PubMed ID: 22107687
    [Abstract] [Full Text] [Related]

  • 15. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ, Slatopolsky E.
    Nat Clin Pract Endocrinol Metab; 2007 Feb 28; 3(2):134-44. PubMed ID: 17237840
    [Abstract] [Full Text] [Related]

  • 16. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B, Belozeroff V.
    Eur J Clin Invest; 2007 Aug 28; 37(8):607-22. PubMed ID: 17635571
    [Abstract] [Full Text] [Related]

  • 17. Phosphate toxicity and vascular mineralization.
    Razzaque MS.
    Contrib Nephrol; 2013 Aug 28; 180():74-85. PubMed ID: 23652551
    [Abstract] [Full Text] [Related]

  • 18. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.
    Toussaint ND, Kerr PG.
    Nephrology (Carlton); 2007 Oct 28; 12(5):500-9. PubMed ID: 17803475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.